oxazoles has been researched along with Akinetic-Rigid Variant of Huntington Disease in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barker, RA; Green-Thompson, ZW; Griffin, J; Jones, PS; Lazic, SE; Mason, SL; Pugh, PJ; Rowe, JB; Rubinsztein, DC; Underwood, BR | 1 |
| Alves-Silva, J; Carvalho, TG; Conn, PJ; de Souza, JM; Doria, JG; Ferreira-Vieira, TH; Maciel, EMA; Olmo, IG; Ribeiro, FM; Santos, JT; Silva, FR; Silva, NC; Xavier, CQS | 1 |
| Lin, F; Qin, ZH | 1 |
| Acevedo-Arozena, A; Brown, SD; Corrochano, S; Menzies, FM; Renna, M; Rose, C; Rubinsztein, DC; Sadiq, O | 1 |
| Eckenhoff, MF; Liang, G; Wang, Q; Wang, S; Wei, H; Yang, H | 1 |
| Chase, TN; Denaro, A; Foster, NL; Hare, TA; Tamminga, CA | 1 |
| Chase, TN; Denaro, A; Durso, R; Ruggeri, S; Tamminga, CA | 1 |
| Cross, AJ; Waddington, JL | 1 |
| Goetz, IE; Hamel, E; Roberts, E | 1 |
| Charlton, M; Goldblatt, D; Joynt, RJ; Shoulson, I | 2 |
| Chase, TN; Frohman, LA; Neophytides, A; Tamminga, CA | 1 |
1 review(s) available for oxazoles and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Degradation of misfolded proteins by autophagy: is it a strategy for Huntington's disease treatment?
Topics: Autophagy; Carbamazepine; Humans; Huntingtin Protein; Huntington Disease; Lithium; Mutant Proteins; Nerve Tissue Proteins; Oxazoles; Peptides; Rilmenidine; Sirolimus; Trehalose; Trinucleotide Repeat Expansion; Valproic Acid | 2013 |
3 trial(s) available for oxazoles and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
THIP treatment of Huntington's disease.
Topics: Adult; Clinical Trials as Topic; Disability Evaluation; Double-Blind Method; Female; Homovanillic Acid; Humans; Huntington Disease; Isoxazoles; Male; Middle Aged; Oxazoles | 1983 |
Huntington's disease: treatment with muscimol, a GABA-mimetic drug.
Topics: Amanita; Betaine; Clinical Trials as Topic; Double-Blind Method; Humans; Huntington Disease; Isoxazoles; Oxazoles | 1977 |
Huntington's disease: treatment with muscimol, a GABA-mimetic drug.
Topics: Activities of Daily Living; Adolescent; Adult; Clinical Trials as Topic; Cognition; Double-Blind Method; Female; gamma-Aminobutyric Acid; Humans; Huntington Disease; Male; Middle Aged; Muscimol; Oxazoles; Placebos | 1978 |
8 other study(ies) available for oxazoles and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease.
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Brain; Female; Humans; Huntington Disease; Longitudinal Studies; Magnetic Resonance Imaging; Male; Metabolomics; Middle Aged; Neuropsychological Tests; Oxazoles; Retrospective Studies; Rilmenidine; Time Factors; Treatment Outcome; Young Adult | 2017 |
The mGluR5 positive allosteric modulator VU0409551 improves synaptic plasticity and memory of a mouse model of Huntington's disease.
Topics: Animals; Conditioning, Classical; Dendritic Spines; Gene Expression Regulation; Huntington Disease; Memory Disorders; Mice; Mice, Inbred C57BL; Motor Activity; Neuronal Plasticity; Oxazoles; Pyridines; Receptor, Metabotropic Glutamate 5; Recognition, Psychology; Signal Transduction; Synapses | 2018 |
Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.
Topics: Animals; Autophagy; Cells, Cultured; Huntingtin Protein; Huntington Disease; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Oxazoles; Peptides; Rilmenidine; Rotarod Performance Test | 2010 |
The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
Topics: Anesthetics, Inhalation; Animals; Calcium; Cell Survival; Cells, Cultured; Corpus Striatum; Desflurane; Endoplasmic Reticulum; Gene Knock-In Techniques; Homeostasis; Huntingtin Protein; Huntington Disease; Isoflurane; Macrocyclic Compounds; Methyl Ethers; Mice; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Oxazoles; Sevoflurane | 2011 |
Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
Topics: Adult; Apomorphine; Arecoline; Dopamine; Female; gamma-Aminobutyric Acid; Growth Hormone; Humans; Huntington Disease; Male; Muscimol; Oxazoles; Prolactin | 1983 |
Therapeutic failure of GABA agonist treatment in Huntington's disease.
Topics: gamma-Aminobutyric Acid; Humans; Huntington Disease; Isoxazoles; Oxazoles | 1984 |
Glutamic acid decarboxylase and gamma-aminobutyric acid in Huntington's disease fibroblasts and other cultured cells, determined by a [3H]muscimol radioreceptor assay.
Topics: Carboxy-Lyases; Cells, Cultured; Fibroblasts; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Huntington Disease; Kinetics; Muscimol; Oxazoles; Radioligand Assay; Receptors, Cell Surface; Receptors, GABA-A; Skin | 1981 |
Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
Topics: Adult; Aged; Chronic Disease; Female; gamma-Aminobutyric Acid; Growth Hormone; Humans; Huntington Disease; Kinetics; Male; Middle Aged; Muscimol; Oxazoles; Prolactin; Schizophrenia | 1978 |